Trademarkia Logo

Australia

AU$
T2D TIME 2 DISRUPT
Registered: Renewal due

Last updated on 7 Mar 2017

Owner Info

Intarcia Therapeutics, Inc. a Delaware corporation

One Marina Park Drive

Suite 1300, UNITED STATES OF AMERICA

Serial Number

1745854 filed on 12 Jan 2016

Correspondent

Davies Collison Cave Pty Ltd

Level 4,

7 Macquarie Place,

Sydney, NSW, 2000 AUSTRALIA

T2D TIME 2 DISRUPT

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases/disorders

Class [010]
Drug delivery systems; medical apparatus for the administration of pharmaceuticals; medical apparatus for treatment of diabetes, obesity and metabolic Read More

Class [041]
Development and dissemination of educational materials of others in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery techn Read More

Class [042]
Research and development of pharmaceutical preparations, products and technology in the fields of diabetes, obesity, metabolic diseases/disorders, dru Read More

Class [044]
Medical information services, namely, providing information on the topics of diabetes, obesity, and metabolic diseases/disorders and the diagnosis, tr Read More

Mark Details


Serial Number

1745854

Registered On

12 Jan 2016

Renewal On

12 Jan 2026

Mark Type

FANCY

Priority Claim (Convention Details)


Date

17 Jul 2015

Mark Type

US

Legal History


Show more

Status DateAction Taken
7th Mar 2017Amend Name/Address
14th Feb 2017Amendment to Application/Registration
28th Apr 2016IP Right Registration Published
26th Apr 2016Application Status
26th Apr 2016Register Trade Mark
31st Mar 2016Registration fee (5 classes)
18th Feb 2016IP Right Acceptance Published
11th Feb 2016Application Accepted correspondence sent
11th Feb 2016Clear Examination report approved
11th Feb 2016User Created Notice correspondence sent